Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-05

Clinical Trial Update: Phase 1/2 Lyme Vaccine Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for a Lyme borreliosis prophylaxis vaccine completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyme vaccine

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Prophylaxis of Lyme Borreliosis | Phase 1, Phase 2 | Status: COMPLETED